Teeth and Gums Also Benefit from the Healing Power of Aloe Vera
CHICAGO, July 20 /PRNewswire-USNewswire/ -- The aloe vera plant has a long history of healing power. Its ability to heal burns and cuts and soothe pain has been documented as far back as the 10th century. Recently, aloe vera has gained some popularity as an active ingredient in toot...
Investigational Cancer Drug BSI-201 Showed Clinical Benefit in 62% of Patients with Triple-Negative Metastatic Breast Cancer and Significantly Prolonged Survival
PARIS and BRISBANE, California, June 3 /PRNewswire-FirstCall/ --
- Data Highlighted in Plenary Session of 2009 American Society of
Clinical Oncology Annual Meeting
Sanofi-aventis (EURONEXT: SAN and NYSE: SNY ) and its fully owned
subsidiary, BiPar Sciences, today announced resu...
MitraClip(R) Therapy Data Demonstrate Clinical Benefit in High-Risk Patients With Mitral Regurgitation
EVEREST High-Risk Registry Data Show Improved Symptomatic Status, Cardiac Function and Reduced rate of Hospitalization for Congestive Heart Failure in both Functional and Degenerative MR Patient Populations
BARCELONA, Spain, May 20 /PRNewswire/ -- Results show percutaneous mitral repair using...
New MADIT II Clinical Data Analysis Shows Long-Term Survival Benefit for Implantable Defibrillator Therapy
Analysis indicates that one life is now saved for every six patients who receive an ICD
NATICK, Mass., May 14 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX ) today announced that an analysis of long-term data from the MADIT II clinical study demonstrates that the life-s...
Men Treated for Localized Prostate Cancer Could Benefit From Pomegranate Juice Consumption
LINTHICUM, Md., April 27 /PRNewswire-USNewswire/ -- Pomegranate juice may slow the progression of post-treatment prostate cancer recurrence, according to new long-term research results being presented at the 104th Annual Scientific Meeting of the American Urological Association (AUA). Researcher...
MitraClip(R) Therapy Data Shows Important Clinical Benefit in High Risk Patients With Functional Mitral Regurgitation at 12-Month Follow Up
EVEREST High-Risk Registry Data Shows Improved Symptomatic Status and Cardiac Function in Functional MR Patients Treated with the MitraClip(R) System
ORLANDO, Fla., March 28 /PRNewswire/ -- Percutaneous mitral valve repair using the MitraClip(R) system in symptomatic high-risk surgical patien...
Diabetes Patients with High Triglycerides and Low HDL Cholesterol Get the Most Benefit From Fenofibrate Treatment: New Data From the FIELD Study
SYDNEY, Australia, Feb. 26 /PRNewswire/ -- Fenofibrate treatment reduces
cardiovascular disease (CVD) risk (defined by total cardiovascular events: the
composite of cardiovascular death, myocardial infarction, stroke, and coronary
and carotid revascularization) in patients with type 2 diabetes...
New Analysis Estimates Numbers of Older U.S. Adults Who May Benefit From Statin Therapy
American Heart Association rapid access journal report:
A new analysis estimates more than 11 million older Americans could be newly eligible for statin therapy if findings from the JUPITER trial are adopted into guidelines.
That could take the...
Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery
- Femara showed reduced risk of death by 13% (P=0.08), despite inclusion of patients crossing over from tamoxifen to Femara therapy
- In a separate censored analysis excluding patients after they crossed over to Femara, reduction in risk of death was 19%
- Long-term follow-up fro...
Congresswoman Supporting Spinal Cord Research Intended to Benefit U.S. Veterans
MIAMI, Oct. 22 /PRNewswire-USNewswire/ -- Congresswoman Debbie
Wasserman Schultz will present a new initiative with St. Thomas University
and the U.S. Department of Defense to support spinal cord injury research.
St. Thomas University Biology Professor Jeffery Alan Plunkett - a leader in
12-Month ATLANTA Trial Data Show Sustained Benefit of Catania(TM) Stent in Treatment of De Novo Coronary Lesions
'New Class' of Stent with Polyzene(R)-F Surface Treatment Maximizes
Endothelialization; Reduces Restenosis, Thrombogenicity, Need for Long-Term
Dual Antiplatelet Therapy
WASHINGTON, Oct. 13 /PRNewswire/ -- Clinical investigators at today's
"Innovative Devices and Futuristic Therapies" sessio...
CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients
Several abstracts highlighting CIMZIA's long-term benefits and value in
moderate to severe Crohn's disease patients presented at American College
of Gastroenterology (ACG)
ORLANDO, Fla. Oct. 7 /PRNewswire-FirstCall/ -- Data from two studies
presented this week by UCB at the American College ...
'Friendly' Bacteria Can Benefit Health Throughout the Lifecycle
Experts Discuss Promising Research at The American College of Nutrition Annual Meeting
WASHINGTON, Oct. 6 /PRNewswire/ -- New research on the benefits of
probiotics in children and seniors was presented at The American College of
Nutrition (ACN) Annual Meeting in a ...
Olanzapine Long-Acting Injection (LAI) Shown to Maintain Treatment Benefit in Schizophrenia for up to Six Months
BARCELONA, Spain, Sept. 2 /PRNewswire-FirstCall/ -- Final results from
a 24-week study presented today at a major medical meeting in Barcelona
suggest that investigational olanzapine long-acting injection (LAI)
therapeutic doses showed a maintenance of treatment benefit
for up to six
Shingles Pain Treatment Will Benefit More Patients
LONDON, August 21 /PRNewswire/ -- The medicated pain relief plaster,
(Versatis) is now approved by the Scottish Medicines Consortium (SMC) for
restricted use within NHS Scotland for patients suffering pain following
shingles(1) http://www.scottishmedicines.org.uk/smc/5850.html . This
Nemours Center for Childhood Cancer Research Team at the Alfred I. duPont Hospital for Children Identifies the Function of a Biomarker Present in Prostate Cancer Cells: New Insight into Therapeutic Benefit for Patients with Advanced Prostate Cancer
WILMINGTON, Del., July 17 /PRNewswire/ -- The research team at the
Nemours Center for Childhood Cancer Research (NCCCR), a newly established
division of Nemours Biomedical Research at the Alfred I. duPont Hospital
for Children has discovered that the biomarker called prostate specific
Preliminary Phase 2 Results of R788 in Lymphoma Show Benefit in Diffuse Large B-Cell and SLL/CLL
Results to be Presented at Lymphoma Meeting in Lugano, Switzerland
SOUTH SAN FRANCISCO, Calif., June 3 /PRNewswire-FirstCall/ -- Rigel
today reported an abstract providing preliminary results of a Phase 2
clinical trial of its oral Syk inhibitor, R788 (fostamatinib disodium), in
Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer
- Zometa when added to hormone therapy, following surgery, significantly reduced the risk of cancer returning or death by 36% beyond clinical benefits achieved with hormone therapy alone(1) - Findings may allow clinicians to improve standard of care for
premenopausal women diagn...
Patients with Pancreatic Cancer Can Benefit From Avastin(R) Plus Tarceva(R)
- Results Confirm Previously Demonstrated Survival Advantages of Tarceva in This Difficult-to-Treat Disease - ABSTRACT No: 4507
BASEL, Switzerland, May 31 /PRNewswire/ -- Adding Avastin (bevacizumab)
to a combination of Tarceva (erlotinib) and chemothe...
Node-Negative Early Stage Breast Cancer Patients Benefit from Taxotere(R)-Based Chemotherapy
First Phase III study performed solely in high risk node-negative
population to show significant improvement in Disease Free Survival (DFS)
BRIDGEWATER, N.J., May 27 /PRNewswire-FirstCall/ -- Sanofi-aventis and
GEICAM (Grupo Espanol de Investigacion en Cancer de Mama) announced today
PEGASYS(R)/COPEGUS(R) Show Benefit in Hard-to-Treat Latino Population with Hepatitis C
- Largest prospective study in under-treated and under-studied population (The LATINO Study) provides important insights -
SAN DIEGO, Calif., May 18 /PRNewswire/ -- Roche today announced results
from the LATINO study, the largest prospective study to evaluate the
response of Latino w...
Omega 3 Fatty Acids Bound to Phospholipids has Potential Benefit for Attention-Deficit Hyperactivity Disorder (ADHD)
GREEN BAY, Wis., May 15 /PRNewswire/ -- Omega 3 fatty acids bound to
phospholipids deserves to be further considered as a credible natural
alternative and may have beneficial effect on impulsivity in ADHD patients,
recent in vivo French study reveals. While several studies have reported
Steroids Provide No Survival Benefit for Children With Bacterial Meningitis
-Large Study Shows Benefits Differ from those in Adults-
PHILADELPHIA, May 6 /PRNewswire-USNewswire/ -- Corticosteroids given to
children who are hospitalized for bacterial meningitis do not provide a
benefit in survival or in reduced hospital stays, according to a large
Novel Small Molecule Therapy Shows Benefit for Anemic Patients Via Hydration of Red Blood Cells
WASHINGTON, Feb. 5 /PRNewswire-USNewswire/ -- Researchers are
identifying innovative therapeutics for sickle cell anemia that focus on
specific factors in the disease's progression, such as the important role
of hydration of the red blood cells. According to a study prepublished
online in Bloo...
IDM Pharma Announces Non-Binding Opinion of the European Committee for Medicinal Products for Human Use (CHMP) that Mifamurtide (L-MTP-PE) Provides a Possible Clinical Benefit in Survival
CHMP grants Company extension to address remaining questions on Marketing Authorization Application
IRVINE, Calif., Jan. 25 /PRNewswire-FirstCall/ -- IDM Pharma, Inc.
(Nasdaq: IDMI ) today announced that the Company recently presented to the
Committee for Medicinal Produc...
Cogentus Pharmaceuticals Begins Clinical Study to Confirm the Full Antiplatelet Benefit of New Combination Medicine CGT-2168
MENLO PARK, Calif., Jan. 16 /PRNewswire/ -- Cogentus Pharmaceuticals,
Inc. today announced that dosing has begun in a clinical study to confirm
the full antiplatelet activity of its novel combination medicine CGT-2168.
CGT-2168 is a once-daily capsule that combines clopidogrel (currently
Physicians Will Benefit from Medical Software Advice Website
Today Software Advice launched its Medical Software Advice website ( www.softwareadvice.com/medical ), a free resource designed to match medical software buyers with the right technology for their practices.
"The market for medical software is booming, but the software vendor landscape is...
Rifalazil Trial (PROVIDENCE-1) Fails to Provide Significant Clinical Benefit in Patients With Peripheral Arterial Disease
LEXINGTON, Mass., Nov. 7 /PRNewswire/ -- ActivBiotics, Inc. today
announced the results of its PROVIDENCE-1 clinical trial, which evaluated
the effect of rifalazil in the treatment of intermittent claudication,
associated with peripheral arterial disease (PAD). The results demonstrated
Synvista Therapeutics Highlights New Data Demonstrating the Clinical Benefit of Vitamin E Therapy in Patients Identified on the Basis of Haptoglobin Phenotype Testing
MONTVALE, N.J., Nov. 5 /PRNewswire-FirstCall/ -- Synvista Therapeutics,
Inc. (Amex: SYI ) announces results of a clinical trial known as the ICARE
study, being presented today at the American Heart Association's (AHA)
Scientific Sessions 2007 in Orlando, Florida. The study demonstrated that
Long-Term Data from a Landmark Phase III Trial Show Survival Benefit at Three- and Four-Years in Patients with Glioblastoma multiforme
LOS ANGELES, Oct. 30 /PRNewswire-FirstCall/ -- Schering-Plough Corp.
and the European Organisation for the Research and Treatment of Cancer
(EORTC) announced long-term follow-up results from the landmark Phase III
trial conducted by the EORTC and the National Cancer Institute of Canada
Research Study Demonstrates Prolonged Benefit of Fitness Program for Bladder Control & Sexual Function in Women
CHICAGO, Oct. 25 /PRNewswire-USNewswire/ -- Women's Health Foundation
(WHF) announced the long-term results of a recent research study to
evaluate the groundbreaking fitness and educational program, Total Control
(TM): A Pelvic Wellness Program For Women. The results showed both an
Artists for a New South Africa Will be 'Shaking The Blues' at Gala Benefit November 15, With Performances by Erykah Badu, Nikka Costa, Keb' Mo', Taj Mahal Trio, The Roots, and Guest Stars at The Wiltern in Los Angeles
EVENT CHAIRS INCLUDE JACKSON BROWNE, MORGAN FREEMAN, SAMUEL L. JACKSON, GEORGE LOPEZ, DEBORAH SANTANA, ALFRE WOODARD, AND FOREST WHITAKER
LOS ANGELES, Oct. 24 /PRNewswire/ -- On Thursday, November 15, 2007,
Artists for a New South Africa (ANSA) will host "Shaking The Blues," a
Tracleer(R) Shows Clinical Benefit as Combination Therapy with Sildenafil for Pulmonary Arterial Hypertension
- Studies Show Improvement in Hemodynamics and Delay Disease Progression -
CHICAGO, Oct. 23 /PRNewswire/ -- Actelion Pharmaceuticals US, Inc.
today announced positive results from two trials demonstrating that
Tracleer(R) (bosentan) may be safe and effective as a combination therapy
for the tre...
Volcano Sponsors First Study Designed to Determine if IVUS Can Identify Patients at Risk for Stent Thrombosis and to Demonstrate the Benefit of IVUS Guidance for Procedural Outcome
3,000 Patient Multi-center IVUS Sub-study Part of the Cardiovascular
Research Foundation's ADAPT-DES Study to Quantify Causes and Cures of Drug Eluting Stent Thrombosis
SAN DIEGO, Oct. 22 /PRNewswire-FirstCall/ -- Volcano Corporation
(Nasdaq: VOLC ) [TCT Booth #2013 ...
Evidence of Benefit Lacking for Many Common Ways of Treating Osteoarthritis of the Knee
ROCKVILLE, Md., Oct. 4 /PRNewswire-USNewswire/ -- A new scientific
review released today by HHS' Agency for Healthcare Research and Quality
concludes that evidence of benefit
is lacking for many common ways of
treating osteoarthritis of the knee, including popular dietary supplement
Kosan's Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
Data Presented at ASCO Breast Cancer Symposium; Additional Positive Results Seen Since Presentation at ASCO Annual Meeting in June
Phase I Trial Expanding to Include Alvespimycin Plus Trastuzumab Plus Paclitaxel Regimen
HAYWARD, Calif., Sept. 10 /PRNewswire-F...
Poniard Pharmaceuticals Announces Updated Results of Picoplatin Phase 2 Trial Demonstrating Survival Benefit in Small Cell Lung Cancer Patients
- Results Presented at 12th World Conference on Lung Cancer in Seoul -
SOUTH SAN FRANCISCO, Calif., Sept. 4 /PRNewswire-FirstCall/ -- Poniard
Pharmaceuticals, Inc. (Nasdaq: PARD ), a biopharmaceutical company focused
on oncology, today announced that updated results of its Phase 2 clinical
Poniard Pharmaceuticals Announces Final Picoplatin Data from Phase 2 Small Cell Lung Cancer Trial Demonstrating Survival Benefit
- Final Safety and Efficacy Data Presented at 1st IASLC-ESMO European Lung Cancer Conference -
SOUTH SAN FRANCISCO, Calif., April 23 /PRNewswire-FirstCall/ -- Poniard
Pharmaceuticals, Inc. (Nasdaq: PARD ), a biopharmaceutical company focused
on oncology, today announce...
New Gene Discovery Suggests Which Patients CTI's Brostallicin May Benefit
Cancer drug development guided by genomics
SAN DIEGO, April 14 /PRNewswire-FirstCall/ -- Systems Medicine LLC
(SM), a wholly-owned subsidiary of Cell Therapeutics, Inc. (CTI) (Nasdaq
and MTAX: CTIC), presented data from a preclinical study identifying the
genetic markers in pati...
Progesterone Therapy and Preterm Birth: More Evidence Helps Identify Women Who Can Benefit
WHITE PLAINS, N.Y., AUG. 2 /PRNewswire-USNewswire/ -- Two major studies
published today in The New England Journal of Medicine can help doctors
better identify pregnant women at risk for preterm delivery who can benefit
from progesterone treatment, the March of Dimes Foundation said today. In...